Bio-Techne Corp (TECH) Stock Price, Quote & News

Company Profile

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth f...

Industry: Biotechnology

Sector: Healthcare

Phone: 612 379 8854

Fax: 612 656 4400

Website: www.bio-techne.com

Address:

614 McKinley Place N.E., Minneapolis, United States

Iightning Dec. 5 at 2:15 AM

1ightning® Premium Options Alert (Actionable) Ticker: $TECH Contract: Dec 19 $65C Entry: 1.65 Exit: 2.69 Return: +63.11% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Iightning Dec. 4 at 8:48 PM

1ightning® Premium Options Alert (Actionable) Ticker: $TECH Contract: Dec 19 $65C Entry: 1.65 Exit: 2.69 Return: +63.11% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

BillionerOfKing Dec. 4 at 1:22 PM

$TECH Current Stock Price: $63.85 Contracts to trade: $65 TECH Dec 19 2025 Call Entry: $1.47 Exit: $2.85 ROI: 94% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Iightning Dec. 4 at 4:30 AM

1ightning® Premium Options Alert (Actionable) Ticker: $TECH Contract: Dec 19 $65C Entry: 2.42 Exit: 3.73 Return: +53.96% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Iightning Dec. 3 at 8:55 AM

1ightning® Premium Options Alert (Actionable) Ticker: $TECH Contract: Dec 19 $55C Entry: 10.75 Exit: 17.02 Return: +58.37% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

BEATOFtheMARKET Dec. 2 at 10:51 AM

$TE $TEAM $TECH $TECL $TECX

0 · Reply

Iightning Dec. 1 at 10:42 PM

**1ightning® Premium Options Alert (Actionable)** **Ticker:** $TECH **Contract:** Dec 19 $65C **Entry:** 2.51 **Exit:** 3.22 **Return:** **+28.01% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**

0 · Reply

smartkarma Nov. 28 at 6:07 AM

$TECH | Bio-Techne Braces for a Biotech Funding Revival—Is a Major Upswing Ahead? "Bio-Techne delivered its first-quarter fiscal year 2026 results amidst a challenging market environment. Despite the company’s strategic and..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/bio-techne-braces-for-a-biotech-funding-revival-is-a-major-upswing-ahead

0 · Reply

smartkarma Nov. 28 at 6:02 AM

0 · Reply

Iightning Nov. 26 at 1:28 AM

1ightning® Options Trade Alert (Actionable) | Buy $TECH Dec 19 $65 Call | Enter: $2.47 Exit: $4.74 | Profit: 91.47% ROI | https://1ightning.com

0 · Reply

Bio-Techne Corporation (TECH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 2, 2025, 2:33 PM EST - 2 days ago

Bio-Techne Corporation (TECH) Presents at Evercore 8th Annual Healthcare Conference Transcript

Nov 25, 2025, 7:00 AM EST - 9 days ago

Bio-Techne to Present at Upcoming Investor Conferences

Nov 20, 2025, 9:43 AM EST - 14 days ago

Bio-Techne Corporation (TECH) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 18, 2025, 4:38 PM EST - 16 days ago

Bio-Techne Corporation (TECH) Presents at Stephens Annual Investment Conference 2025 Transcript

Nov 18, 2025, 6:30 AM EST - 16 days ago

Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio

Nov 11, 2025, 11:41 AM EST - 23 days ago

Bio-Techne Corporation (TECH) Presents at Stifel 2025 Healthcare Conference Transcript

Nov 10, 2025, 1:01 PM EST - 24 days ago

Bio-Techne Corporation (TECH) Presents at UBS Global Healthcare Conference 2025 Transcript

Nov 5, 2025, 1:11 PM EST - 4 weeks ago

Bio-Techne Corporation (TECH) Q1 2026 Earnings Call Transcript

Nov 5, 2025, 7:22 AM EST - 4 weeks ago

Bio-Techne misses quarterly sales estimates on weak biotech demand

Nov 5, 2025, 6:30 AM EST - 4 weeks ago

Bio-Techne Releases First Quarter Fiscal 2026 Results

Nov 5, 2025, 6:30 AM EST - 4 weeks ago

BIO-TECHNE DECLARES DIVIDEND

Nov 4, 2025, 9:01 AM EST - 4 weeks ago

AI-Powered Spatial Biology Workflow from Bio-Techne and Nucleai Enables Predictive Biomarker Discovery in Melanoma Patients

Nov 3, 2025, 7:00 AM EST - 4 weeks ago

ScaleReady Announces a G-Rex® Grant has been awarded to Sonoma Biotherapeutics

Oct 28, 2025, 6:30 AM EDT - 5 weeks ago

Bio-Techne Launches ProximityScope™ Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research

Oct 23, 2025, 7:00 AM EDT - 6 weeks ago

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at Children's National Hospital

Oct 15, 2025, 9:00 AM EDT - 7 weeks ago

Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents

Oct 15, 2025, 7:00 AM EDT - 7 weeks ago

Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results

Oct 9, 2025, 7:00 AM EDT - 2 months ago

Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032

Sep 26, 2025, 6:30 AM EDT - 2 months ago

Bio-Techne Advances Spatial Biology Solutions Bridging Translational Research to Clinical Applications

Sep 24, 2025, 6:59 AM EDT - 2 months ago

Bio-Techne Highlights Progress on Climate, Innovation, and Culture in 2025 Sustainability Report

Sep 10, 2025, 2:36 PM EDT - 3 months ago

Bio-Techne Corporation (TECH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 11:36 AM EDT - 3 months ago

Bio-Techne Corporation (TECH) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 9, 2025, 7:00 AM EDT - 3 months ago

ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California

Sep 3, 2025, 3:42 PM EDT - 3 months ago

Bio-Techne Corporation (TECH) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Aug 14, 2025, 7:00 AM EDT - 4 months ago

ScaleReady Announces Award of a G-Rex® Grant to the Gates Institute's Translational Sciences Laboratory

Aug 6, 2025, 6:08 PM EDT - 4 months ago

Bio-Techne (TECH) Q4 EPS Rises 8.2%

Aug 6, 2025, 12:52 PM EDT - 4 months ago

Bio-Techne Corporation (TECH) Q4 2025 Earnings Call Transcript

Aug 6, 2025, 8:08 AM EDT - 4 months ago

Bio-Techne beats quarterly estimates on strength in protein sciences unit

Aug 6, 2025, 6:30 AM EDT - 4 months ago

Bio-Techne Releases Fourth Quarter Fiscal 2025 Results

Aug 5, 2025, 4:30 PM EDT - 4 months ago

Bio-Techne Announces Exosome Diagnostics Divestiture

Aug 5, 2025, 7:00 AM EDT - 4 months ago

ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine

Jul 31, 2025, 9:52 AM EDT - 4 months ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

BSX CAH DXCM EW ISRG LLY PODD

Jul 31, 2025, 7:00 AM EDT - 4 months ago

ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering

Jul 28, 2025, 1:19 PM EDT - 4 months ago

Bio-Techne Q4 Preview: NIH Funding Cut And Tariffs Impacts, Initiate At Sell

Jul 17, 2025, 7:00 AM EDT - 5 months ago

Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results

Jul 15, 2025, 9:03 AM EDT - 5 months ago

Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology

Jul 15, 2025, 7:00 AM EDT - 5 months ago

Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection

Jul 14, 2025, 7:00 AM EDT - 5 months ago

Bio-Techne's Simple Western™ Technology Utilized in Recent FDA Approval of ZEVASKYN™ Cell-Based Gene Therapy

ABEO

Jun 24, 2025, 7:00 AM EDT - 5 months ago

Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development

Jun 10, 2025, 7:00 AM EDT - 6 months ago

ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics

May 29, 2025, 7:00 AM EDT - 6 months ago

Bio-Techne to Present at Investor Conferences

May 14, 2025, 7:00 AM EDT - 7 months ago

ScaleReady awards multiple G-Rex® Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA)

May 12, 2025, 7:00 AM EDT - 7 months ago

Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025

May 8, 2025, 9:30 AM EDT - 7 months ago

Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing

May 8, 2025, 7:00 AM EDT - 7 months ago

Bio-Techne to Present at the BofA Securities 2025 Health Care Conference

May 7, 2025, 10:38 AM EDT - 7 months ago

Bio-Techne Corporation (TECH) Q3 2025 Earnings Call Transcript

May 7, 2025, 8:18 AM EDT - 7 months ago

Bio-Techne exceeds profit expectations, announces new share buyback plan

May 7, 2025, 6:30 AM EDT - 7 months ago

BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM

May 7, 2025, 6:30 AM EDT - 7 months ago

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS

Iightning Dec. 5 at 2:15 AM

1ightning® Premium Options Alert (Actionable) Ticker: $TECH Contract: Dec 19 $65C Entry: 1.65 Exit: 2.69 Return: +63.11% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Iightning Dec. 4 at 8:48 PM

1ightning® Premium Options Alert (Actionable) Ticker: $TECH Contract: Dec 19 $65C Entry: 1.65 Exit: 2.69 Return: +63.11% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

BillionerOfKing Dec. 4 at 1:22 PM

0 · Reply

Iightning Dec. 4 at 4:30 AM

1ightning® Premium Options Alert (Actionable) Ticker: $TECH Contract: Dec 19 $65C Entry: 2.42 Exit: 3.73 Return: +53.96% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

Iightning Dec. 3 at 8:55 AM

1ightning® Premium Options Alert (Actionable) Ticker: $TECH Contract: Dec 19 $55C Entry: 10.75 Exit: 17.02 Return: +58.37% ROI Unlock VIP Access → https://1ightning.com

0 · Reply

BEATOFtheMARKET Dec. 2 at 10:51 AM

$TE $TEAM $TECH $TECL $TECX

0 · Reply

Iightning Dec. 1 at 10:42 PM

0 · Reply

smartkarma Nov. 28 at 6:07 AM

0 · Reply

smartkarma Nov. 28 at 6:02 AM

0 · Reply

Iightning Nov. 26 at 1:28 AM

1ightning® Options Trade Alert (Actionable) | Buy $TECH Dec 19 $65 Call | Enter: $2.47 Exit: $4.74 | Profit: 91.47% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 25 at 11:35 AM

1ightning® Options Trade Alert (Actionable) | Buy $TECH Dec 19 $65 Call | Enter: $2.47 Exit: $4.74 | Profit: 91.47% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 25 at 12:31 AM

1ightning® Options Trade Alert (Actionable) | Buy $TECH Dec 19 $65 Call | Enter: $2.47 Exit: $4.74 | Profit: 91.47% ROI | https://1ightning.com

0 · Reply

SPYmyQQQ Nov. 24 at 7:53 PM

🎯 Target Hit 🏁 📨 From Nov 12, 2025 🏛️ $TECH 💵 Entry: $61.3900 ✅ Exit: $63.1028 💰 P/L: +2.79% 👉 FREE TRIAL! spymyqqq/join/

0 · Reply

BEATOFtheMARKET Nov. 23 at 5:50 PM

$TE $TEAM 🔥 $TECH $TECL $TECX 🔥

0 · Reply

Iightning Nov. 21 at 9:48 PM

1ightning® Options Trade Alert (Actionable) | Buy $TECH Dec 19 $60 Call | Enter: $2.85 Exit: $4.41 | Profit: 54.66% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 21 at 12:54 AM

1ightning® Options Trade Alert (Actionable) | Buy $TECH Dec 19 $60 Call | Enter: $2.85 Exit: $4.41 | Profit: 54.66% ROI | https://1ightning.com

0 · Reply

JarvisFlow Nov. 20 at 2:13 PM

Argus Research has updated their rating for Bio-Techne ( $TECH ) to Buy with a price target of 68.

0 · Reply

Iightning Nov. 19 at 10:24 PM

1ightning® Options Trade Alert (Actionable) | Buy $TECH Dec 19 $60 Call | Enter: $2.85 Exit: $4.41 | Profit: 54.66% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 19 at 6:45 AM

1ightning® Options Trade Alert (Actionable) | Buy $TECH Dec 19 $60 Call | Enter: $2.85 Exit: $4.41 | Profit: 54.66% ROI | https://1ightning.com

0 · Reply

OfficialStocktwitsUser Nov. 14 at 4:03 PM

$TECH RSI: 32.64, MACD: 0.0440 Vol: 2.51, MA20: 61.66, MA50: 58.10 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Jimmy3Stylz Nov. 11 at 2:26 PM

$TECH congress doesn’t miss! https://x.com/pelositracker/status/1987934381005304006?s=61&t=3Qx9I7Gngmu8kjm-5F7m9Q

1 · Reply

BillionerOfKing Nov. 11 at 1:22 PM

$TECH Current Stock Price: $57.48 Contracts to trade: $55 TECH Nov 21 2025 Call Entry: $3.24 Exit: $5.08 ROI: 57% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Market Cap	9.81B
Revenue (ttm)	1.22B
Net Income (ttm)	73.40M
EPS (ttm)	N/A
PE Ratio	36.60
Forward PE	37.81
Profit Margin	6.02%
Debt to Equity Ratio	0.15

Volume	1,442,700
Avg Vol	2,164,118
Day's Range	N/A - N/A
Shares Out	155.81M
Stochastic %K	67%
Beta	1.46
Analysts	Strong Sell
Price Target	$68.58